La cadena de opciones muestra datos clave de las opciones de acciones de Intelligent Bio Solutions a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Intelligent Bio Solutions..

Intelligent Bio Solutions (NASDAQ:INBS) Bolsa, Cadena de Opciones

Intelligent Bio Solutions

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.

News

Health Care

Contracts

Market-Moving Exclusives

Exclusives

General

Intelligent Bio Solutions Inc. - Common Stock

INBS

Intelligent Bio Solutions colabora con IVY Diagnostics para impulsar su solución de detección de drogas en Europa y Medio Oriente.

Intelligent Bio Solutions se expande en Europa y Medio Oriente con IVY Diagnostics

Intelligent Bio Solutions Inc

Press Releases

Intelligent Bio Solutions Adds Next-Gen Wearable for Extended Drug Detection to Product Offering, Strengthening Leadership in Non-Invasive Testing

Intelligent Bio Solutions Accelerates Global Growth with SmarTest® Patch Agreement, Reinforces U.S. Expansion Path as FDA Approval Remains a Strategic Priority

Intelligent Bio Solutions to Strengthen FDA 510(k) Submission with New Positive Data Demonstrating Ultra-Precise Fingerprint Sweat Detection and Platform Resilience

Intelligent Bio Solutions Inc. Enters Into Agreements to Raise $3.8 Million in Gross Proceeds

Intelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport Operator

Intelligent Bio Solutions Strengthens FDA 510(k) Package with New Cybersecurity and Performance Data Ahead of Planned U.S. Market Launch

Earnings

Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum

Intelligent Bio Solutions to Participate in the Sidoti Micro-Cap Virtual Conference on August 20-21, 2025

Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational Efficiencies

Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in July

Adagio Medical Holdings, Inc - Common Stock

Adagio Medical Holdings

Aethlon Medical

Autonomix Medical

Biomerica

Co-Diagnostics

DIH Holding US, Inc. - Class A Common Stock

DIH Holding US

Ekso Bionics Holdings, Inc. - Common Stock

Ekso Bionics Holdings

Femasys

HeartSciences

SeaStar Medical Holding Corporation - Common Stock

SeaStar Medical Holding

Iridex

Lifeward

Spectral AI

Neuraxis

Nuwellis

enVVeno Medical Corporation - Common Stock

enVVeno Medical

Nexalin Technology

PAVmed

Profusa

Predictive Oncology

SINTX Technologies

Strata Skin Sciences, Inc. - Common Stock

Strata Skin Sciences

Tenon Medical

Beyond Air

Xylo Technologies Ltd. - American Depositary Shares

Xylo Technologies

Comments

Intelligent Bio Solutions

Intelligent Bio Solutions (INBS) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL